[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637189":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":52,"collaborators":26,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":26,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":26,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":77,"overallStatus":40,"whyStopped":26,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Beni-Suef University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Pulsed Electromagnetic Field Therapy Group","EXPERIMENTAL","Participants in this group will receive pulsed electromagnetic field therapy in addition to stable standard medical care.",[13],"Device: Pulsed Electromagnetic Field Therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham Pulsed Electromagnetic Field Therapy Group","SHAM_COMPARATOR","Participants in this group will receive sham pulsed electromagnetic field therapy sessions in addition to stable standard medical care.",[19],"Device: Sham pulsed electromagnetic field therapy",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Pulsed Electromagnetic Field Therapy","PEMF will be applied using a low-frequency pulsed electromagnetic stimulation device with sinusoidal waveform output targeting the lower abdominal and pelvic regions. Treatment sessions will be administered three times weekly for 8 consecutive weeks, with each session lasting approximately 20 minutes. Treatment parameters will include pulsed frequency ranging from 10 Hz, magnetic field intensity ranging from 2 mT, and pulse duration ranging from 250 microseconds. Standard medical care include stable hormonal therapy and prescribed analgesic medications without modification during the study period.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Sham pulsed electromagnetic field therapy","Participants in this group will receive sham pulsed electromagnetic field therapy sessions in addition to stable standard medical care. The sham device will appear identical to the active device in shape, sound, and operating indicators without delivering therapeutic electromagnetic output. Session duration, participant positioning, and treatment frequency will match those of the experimental group.",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Marwa Elsayed Mohamed Lecturer, Ph.D","CONTACT","01141825442","Marwa.elsayed@pt.bsu.edu.eg",[38],{"facility":39,"status":40,"city":41,"state":26,"zip":26,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Outpatient clinic, faculty of Physical Therapy, Beni Suef University","RECRUITING","Banī Suwayf","Egypt","EG",{"type":45,"coordinates":46},"Point",[47,48],31.09785,29.07441,{"lat":48,"lon":47},[51],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Marwa Elsayed Mohamed, PhD","Lecturer of Physiotherapy for Women Health","100637189","efficacy-of-pulsed-electromagnetic-field-therapy-on-women-with-endometriosis-100637189",false,"NCT07592403","Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis","Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis, A Randomized Controlled Trial","Inclusion Criteria:\n\n1. Women aged 18 to 45 years\n2. Clinically, radiologically, or laparoscopically diagnosed endometriosis\n3. Chronic pelvic pain persisting for at least 6 months\n4. Stable pharmacological or hormonal treatment for at least 3 months before enrollment\n5. Ability to understand study procedures and provide written informed consent\n\nExclusion Criteria:\n\n1. Pregnancy or planned pregnancy during the study period\n2. History of gynecological or pelvic malignancy\n3. Active pelvic inflammatory disease or acute pelvic infection\n4. Implanted electronic medical devices such as pacemakers or neurostimulators\n5. Previous pelvic surgery within the past 6 months\n6. Participation in another clinical trial during the previous 3 months\n7. Neurological, rheumatological, or severe musculoskeletal disorders affecting assessment procedures\n8. Contraindications to electromagnetic therapy","FEMALE","18 Years","45 Years",{"count":67,"type":68},60,"ESTIMATED","INTERVENTIONAL",[71],"NA","This randomized, sham-controlled, double-blinded clinical trial aims to investigate the effects of pulsed electromagnetic field therapy (PEMF) on pain intensity, quality of life, and pelvic floor morphometric changes assessed by four-dimensional trans perineal ultrasound (4D TPUS) in women diagnosed with endometriosis. Participants will be randomly allocated into either a PEMF therapy group or a sham PEMF control group. Both groups will continue receiving stable standard medical care throughout the study period. Assessments will be conducted at baseline, after completion of the 8-week intervention period, and at 3-month follow-up.",[74,75,76],"Endometriosis","Pulsed Electromagnetic Therapy","Trans Perineal Ultrasound",[74,23,78],"trans perineal ultrasound","2026-05-15",{"date":81,"type":82},"2026-05-19","ACTUAL",{"date":84,"type":82},"2026-05-16",{"date":86,"type":68},"2027-01-30",{"name":5,"class":6},1]